Perfusable organs for transplantation

Logo
CSA Group
Standards Development Organisation:
Working Program:
Designation Number:
Z900.2.3
Standard Type:
National Standard of Canada - Domestic
Standard Development Activity:
Amendment Revision
ICS code(s):
11.020
11.100
Status:
Proceeding to development
SDO Comment Period Start Date:
SDO Comment Period End Date:
Posted On:

Scope:

Scope

1.1 Purpose

This Standard addresses issues related to the safety of human perfusable organs used for transplantation. It includes quality system requirements and aspects of safety for potential and actual donors and recipients, personnel, and others who might be exposed to, or affected by, the transplantation of perfusable organs.

1.2 Areas of application

This Standard applies to establishments (or facilities) and individuals involved in the following activities related to perfusable organs intended for transplantation:

a) processing;

b) evaluation of the safety of perfusable organs prior to transplantation;

c) recordkeeping;

d) error, accident, and adverse reaction reporting;

e) distribution;

f) importation or exportation; and

g) recall of human organs intended for transplantation.

1.3 Inclusions

This Standard is intended to serve as a benchmark and provide minimum requirements for the verification of safe practices in each of the activities listed in Items a) to g) in Clause 1.2.

Note: Examples of establishments or individuals include the following:

a) organ donation organizations (ODOs);

b) transplant programs and facilities (hospitals and special clinics); and

c) HLA laboratories.

1.4 Limitations

This Standard is not intended to replace detailed specifications and standard operating procedures but is intended to be used in their preparation.

1.5 Priority

This Standard contains particular requirements for perfusable organs for transplantation and is intended to be used with CAN/CSA-Z900.1. Where differences exist, the requirements of this Standard apply.

Project need:

Project Need
To align Canadian requirements with those of the FDA (Food and Drug Administration) in the US, to ensure Canada can continue to import perfusable organs for transplantation from the US once the FDA will have changed their requirements on this topic.

Note: The information provided above was obtained by the Standards Council of Canada (SCC) and is provided as part of a centralized, transparent notification system for new standards development. The system allows SCC-accredited Standards Development Organizations (SDOs), and members of the public, to be informed of new work in Canadian standards development, and allows SCC-accredited SDOs to identify and resolve potential duplication of standards and effort.

Individual SDOs are responsible for the content and accuracy of the information presented here. The text is presented in the language in which it was provided to SCC.